We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+20.96%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$976M
AUM Growth
+$122M
Cap. Flow
-$88.9M
Cap. Flow %
-9.11%
Top 10 Hldgs %
19.05%
Holding
231
New
35
Increased
79
Reduced
34
Closed
30

Top Buys

Rank Stock Value
1
REVG
REV Group
REVG
+$13.5M
2
SHAK icon
Shake Shack
SHAK
+$6.72M
3
SKYW icon
Skywest
SKYW
+$6.1M
4
OSIS icon
OSI Systems
OSIS
+$5.68M
5
GRBK icon
Green Brick Partners
GRBK
+$4.91M

Sector Composition

Rank Sector Weight
1 Technology 26.42%
2 Industrials 19.31%
3 Healthcare 13.08%
4 Financials 9.58%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRCC icon
126
BRC Inc
BRCC
$250M
$2.37M 0.24%
+553,411
New +$2.29M
VRT icon
127
Vertiv
VRT
$105B
$2.2M 0.23%
26,913
-3,912
-13% -$246K
KALV
128
DELISTED
KalVista Pharmaceuticals
KALV
$2.17M 0.22%
+182,644
New +$2.44M
EYPT icon
129
EyePoint Inc
EYPT
$1.2B
$2.06M 0.21%
99,765
+46,529
+87% +$1.15M
LRCX icon
130
Lam Research
LRCX
$390B
$1.97M 0.2%
20,240
+1,650
+9% +$145K
MGY icon
131
Magnolia Oil & Gas
MGY
$5.94B
$1.9M 0.19%
+73,082
New +$1.6M
IWC icon
132
iShares Micro-Cap ETF
IWC
$1.5B
$1.85M 0.19%
+15,251
New +$1.75M
LBRT icon
133
Liberty Energy
LBRT
$3.25B
$1.85M 0.19%
+89,050
New +$1.76M
VRTX icon
134
Vertex Pharmaceuticals
VRTX
$126B
$1.82M 0.19%
4,343
-3,479
-44% -$1.47M
FLS icon
135
Flowserve
FLS
$10.2B
$1.67M 0.17%
36,638
+15,062
+70% +$634K
IONS icon
136
Ionis Pharmaceuticals
IONS
$9.4B
$1.66M 0.17%
38,186
+7,741
+25% +$369K
OBDC icon
137
Blue Owl Capital
OBDC
$5.74B
$1.64M 0.17%
106,685
DKNG icon
138
DraftKings
DKNG
$11.9B
$1.53M 0.16%
33,660
+4,139
+14% +$168K
AAPL icon
139
Apple
AAPL
$4.57T
$1.48M 0.15%
8,637
-24,762
-74% -$4.5M
DDOG icon
140
Datadog
DDOG
$84B
$1.38M 0.14%
11,198
HUBS icon
141
HubSpot
HUBS
$10.5B
$1.32M 0.14%
2,110
+29
+1% +$17.4K
CW icon
142
Curtiss-Wright
CW
$25.5B
$1.24M 0.13%
4,838
+139
+3% +$32.3K
ROST icon
143
Ross Stores
ROST
$81.9B
$1.03M 0.11%
6,988
+2,186
+46% +$313K
XYZ
144
Block Inc
XYZ
$47.5B
$977K 0.1%
11,553
+5,067
+78% +$366K
NET icon
145
Cloudflare
NET
$107B
$903K 0.09%
9,323
+4,260
+84% +$386K
ABNB icon
146
Airbnb
ABNB
$107B
$899K 0.09%
5,450
CX icon
147
Cemex
CX
$16.3B
$860K 0.09%
95,435
+2,776
+3% +$22.2K
ZS icon
148
Zscaler
ZS
$27.3B
$822K 0.08%
4,267
+2,442
+134% +$546K
CRWD icon
149
CrowdStrike
CRWD
$218B
$758K 0.08%
9,460
+1,624
+21% +$124K
ADBE icon
150
Adobe
ADBE
$105B
$631K 0.06%
1,250
-2,472
-66% -$1.42M

Similar funds

Nicholas Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Nicholas Investment Partners held 231 positions worth $976M, up 14% from $855M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nicholas Investment Partners withdrew a net $88.9M in Q1 2024, closing 30 positions and reducing 34 holdings. Its most notable exit was Cymabay Therapeutics, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in REV Group worth $15.9M.

  • Nicholas Investment Partners's largest Q1 2024 buy was REV Group: 720,446 shares worth $15.9M.
  • Nicholas Investment Partners added most to Kontoor Brands in Q1 2024, an estimated $3.93M increase.
  • Nicholas Investment Partners's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $16.7M.
  • Nicholas Investment Partners fully exited Cymabay Therapeutics in Q1 2024, selling an estimated $10.3M.
  • Nicholas Investment Partners's ten largest holdings make up 19% of its $976M portfolio in Q1 2024.
  • Nicholas Investment Partners opened 35 new positions and closed 30 in Q1 2024.
  • Nicholas Investment Partners's portfolio value rose 14% quarter-over-quarter to $976M.

Based on Nicholas Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.